X

Articles

02Jan

IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization

0 Comments | | Return |

VP of Scientific Affairs Marion Lanteri recently joined the International Plasma and Fractionation Association (IPFA) executive board, as CTS joined as a member. She said of her appointment, “It is my honor to represent CTS internationally and to create new opportunities. I am also grateful that CTS invested in this membership, and I will make the best of it.” 

Marion_Lanteri_emailIPFA’s mission is to support and promote the activities of nonprofit organizations around the globe engaged in the collection and fractionation of plasma to enable robust, safe supply and patient access to plasma-derived medicines. Additionally, through education and collaboration with stakeholders, they advocate for public health values and donor health protection.

According to an IPFA article, CTS’s membership brings a new category of contribution to IPFA from nonprofit research and clinical testing institutions. They describe this sector as being at the heart of the association and bringing together the different stakeholders that CTS represents and works with.

President & CEO Sally Caglioti said of the news, “I’m grateful to Marion for representing us with IPFA. Professional networking is a big part of why we have had so many growth opportunities at CTS. Building relationships and trust with external colleagues opens up all kinds of doors.”

Related

Reminder- Check flights and cargo hours for the New Year's Day Holiday

As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...

Read More >

CTS implements Ultrio Plus on the Panther

In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...

Read More >

Reminder-Bio-Rad Geenius HIV 1/2 Implemented

CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...

Read More >

CTS Implements HLA Class I and II Testing on the Gemini

CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...

Read More >

FDA Releases ZIKV Guidance and Grifols ZIKV Assay Licensed- 1st Update

This is the first update to the original CTS communication distributed on July 6th. As previously co...

Read More >

Shipping conditions for Monolisa anti-HBs EIA

After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...

Read More >

Subscribe here to receive CTS updates!

Name